Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. News
  7. Summary
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
Real-time Estimate Cboe BZX  -  01:17 2022-07-01 pm EDT
163.50 USD   +1.02%
06/30BEIGENE : Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tislelizumab Plus Chemotherapy in First-Line Advanced or Metastatic Esophageal Squamous Cell Carcinoma - Form 8-K
PU
06/30BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/30BeiGene Says Esophageal Cancer Combination Therapy Improved Overall Survival in Phase 3 Trial
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Asian ADRs Climb Higher in Tuesday Trading

05/10/2022 | 10:37am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
111, INC. 5.34% 2.17 Delayed Quote.-41.14%
ASLAN PHARMACEUTICALS LIMITED 1.23% 0.5011 Delayed Quote.-55.80%
BEIGENE, LTD. 0.47% 162.49 Delayed Quote.-40.26%
HDFC BANK LIMITED 0.43% 1353.75 Delayed Quote.-8.88%
JUPAI HOLDINGS LIMITED -71.36% 0.0401 Delayed Quote.-86.41%
LEJU HOLDINGS LIMITED -8.51% 2.15 Delayed Quote.-74.02%
PLDT INC. -0.60% 1670 End-of-day quote.-7.84%
SEA LIMITED -0.03% 66.9137 Delayed Quote.-70.11%
SECOO HOLDING ADR A -0.45% 0.223 Delayed Quote.-53.33%
SIFY TECHNOLOGIES LIMITED -1.54% 1.92 Delayed Quote.-39.01%
SO-YOUNG INTERNATIONAL INC. 4.03% 0.8912 Delayed Quote.-73.14%
SY HOLDINGS GROUP LIMITED -0.17% 5.89 Delayed Quote.-24.00%
UNITED MICROELECTRONICS CORPORATION -2.81% 38.05 End-of-day quote.-41.46%
UXIN LIMITED 7.95% 0.4541 Delayed Quote.-73.42%
All news about BEIGENE, LTD.
06/30BEIGENE : Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Tis..
PU
06/30BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/30BeiGene Says Esophageal Cancer Combination Therapy Improved Overall Survival in Phase 3..
MT
06/30BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Ti..
BU
06/30BeiGene Announces Late-Breaking Data at ESMO GI Showing Overall Survival Benefit for Ti..
CI
06/27BeiGene Grants Share Options, Restricted Share Units
MT
06/26Antengene Corporation Limited Announces Clinical Trial Collaboration with BeiGene, Ltd...
CI
06/24Asian ADRs Climb Higher in Friday Trading
MT
06/22BEIGENE : Announces Acceptance of Supplemental Biologics License Application in China for ..
PU
06/22INSIDER SELL : Beigene
MT
More news
Analyst Recommendations on BEIGENE, LTD.
More recommendations
Financials (USD)
Sales 2022 1 434 M - -
Net income 2022 -1 399 M - -
Net cash 2022 3 045 M - -
P/E ratio 2022 -11,2x
Yield 2022 -
Capitalization 16 726 M 16 726 M -
EV / Sales 2022 9,54x
EV / Sales 2023 7,05x
Nbr of Employees 8 300
Free-Float 99,0%
Chart BEIGENE, LTD.
Duration : Period :
BeiGene, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIGENE, LTD.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 161,85 $
Average target price 303,74 $
Spread / Average Target 87,7%
EPS Revisions
Managers and Directors
John V. Oyler Director
Xiao Bin Wu President & Chief Operating Officer
Julia Wang Chief Financial & Accounting Officer
Lai Wang Global Head-Research & Development
Christiane Langer Senior Vice President-Global Medical Affairs
Sector and Competitors
1st jan.Capi. (M$)
BEIGENE, LTD.-40.26%16 726
GILEAD SCIENCES, INC.-14.87%77 529
VERTEX PHARMACEUTICALS28.32%72 069
REGENERON PHARMACEUTICALS, INC.-6.40%63 692
WUXI APPTEC CO., LTD.-12.30%45 031
BIONTECH SE-42.16%36 234